title: Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome.
abstract: Antiphospholipid syndrome patients with recurrent miscarriage have an impairment in fibrinolysis demonstrated by prolonged clot lysis time (CLT) that cannot be attributed to differences in thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels. Patients with unexplained recurrent miscarriage have an impairment in fibrinolysis demonstrated by increased CLT, that can be at least partly explained by higher TAFI antigen levels.
authors.affiliation: Institut Clínic of Gynecology, Obstetrics and Neonatology, Faculty of Medicine-University of Barcelona, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
authors.forename: M Angeles
authors.initials: MA
authors.lastname: Martínez-Zamora
authors.forename: Montserrat
authors.initials: M
authors.lastname: Creus
authors.forename: Dolors
authors.initials: D
authors.lastname: Tassies
authors.forename: Albert
authors.initials: A
authors.lastname: Bové
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Reverter
authors.forename: Francisco
authors.initials: F
authors.lastname: Carmona
authors.forename: Juan
authors.initials: J
authors.lastname: Balasch
mesh_terms: D000026:Abortion, Habitual / Q000097:blood* / Q000209:etiology; D000328:Adult; D016736:Antiphospholipid Syndrome / Q000097:blood* / Q000150:complications; D001777:Blood Coagulation / Q000502:physiology; D001780:Blood Coagulation Tests; D025901:Carboxypeptidase B2 / Q000032:analysis / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D005342:Fibrinolysis / Q000502:physiology; D006801:Humans; D011247:Pregnancy; D013997:Time Factors
chemical_list: D025901:Carboxypeptidase B2